Skip to content

Clinical trials

Medulloblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Country / region: United States Clear all

244 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20018
20028
20034
20049
200511
20068
20077
20086
200910
201013
20115
20123
201311
20145
20158
20166
201714
201812
201912
20206
20217
20229
20233
20243
20254
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150
Terminated29
Active, not recruiting28
Recruiting24
Unknown status4
Withdrawn4
Not yet recruiting2
No longer available1
Suspended1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)53
Pediatric Brain Tumor Consortium16
Children's Oncology Group15
St. Jude Children's Research Hospital12
Giselle Sholler7
Memorial Sloan Kettering Cancer Center6
National Institutes of Health Clinical Center (CC)6
Novartis Pharmaceuticals6
City of Hope Medical Center5
Duke University5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma244
Astrocytoma107
Central Nervous System Neoplasms99
Ependymoma92
Glioma88
Brain Neoplasms82
Oligodendroglioma82
Neuroblastoma73
Choroid Plexus Neoplasms62
Glioblastoma61

Trials

Showing 1 to 25 of 244. Each trial links to its page on Pharma Observatory.

144 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.